| FERROUS SULFATE
Feosol, Fer-In-Sol, Fer-Iron, Fero-Gradumet, Ferospace, Ferralyn, Ferra-TD, Fesofor, Hematinic, Mol-Iron, Novoferrosulfa , Slow-Fe
Feco-T, Femiron, Feostat, Fersamal, Fumasorb, Fumerin, Hemocyte, Ircon-FA, Neo-Fer-50 , Novofumar , Palafer , Palmiron
Fergon, Fertinic , Novoferrogluc , Simron
Classifications: blood former; iron preparation; Therapeutic: antianemic; iron supplement
Pregnancy Category: A
Ferrous Sulfate: 167 mg, 200 mg, 324 mg, 325 mg tablets; 160 mg sustained release tablets, capsules; 90 mg/5 mL syrup; 220 mg/5 mL elixir; 75 mg/0.6 mL drops
Ferrous Fumarate: 63 mg, 100 mg, 200 mg, 324 mg, 325 mg, 350 mg tablets; 100 mg/5 mL suspension; 45 mg/0.6 mL drops
Ferrous Gluconate: 240 mg, 325 mg tablets
Ferrous sulfate: Standard iron preparation that corrects erythropoietic abnormalities induced by iron deficiency but does not stimulate erythropoiesis.
Ferrous gluconate: Claimed to cause less gastric irritation and be better tolerated than ferrous sulfate.
Effectiveness is experienced within 48 h as a sense of well-being, increased vigor, improved appetite, and decreased irritability
(in children). Reticulocyte response begins in about 4 d; it usually peaks in 710 d and returns to normal after 2 or
3 wk. Hemoglobin generally increases by 2 g/dL and hematocrit by 6% in 3 wk.
To correct simple iron deficiency and to treat iron deficiency (microcytic, hypochromic) anemias. Also may be used prophylactically
during periods of increased iron needs, as in infancy, childhood, and pregnancy.
Peptic ulcer, regional enteritis, ulcerative colitis; hemolytic anemias (in absence of iron deficiency), hemochromatosis,
hemosiderosis, patients receiving repeated transfusions, pyridoxine-responsive anemia; cirrhosis of liver.
Hepatic disease; GI diseases; sulfite hypersensitivity; pregnancy (category A).
Route & Dosage
Adult: PO Sulfate (30% elemental iron) 7501500 mg/d in 13 divided doses; Fumarate (33% elemental iron) 200 mg t.i.d. or q.i.d.; Gluconate (12% elemental iron) 325600 mg q.i.d., may be gradually increased to 650 mg q.i.d. as needed and tolerated
Child: PO Sulfate (30% elemental iron) <6 y, 75225 mg/d in divided doses; 612 y, 600 mg/d in divided doses; Fumarate (33% elemental iron) 3 mg/kg t.i.d.; Gluconate (12% elemental iron) <6 y, 100300 mg/d in divided doses; 612 y, 100300 mg t.i.d.
Adult: PO Sulfate Pregnancy, 300600 mg/d in divided doses; Fumarate 200 mg once/d; Gluconate 325600 mg once/d
Child: PO Fumarate 3 mg/kg once/d; Gluconate <6 y, 100300 mg/d in divided doses; 612 y, 100300 mg once/d
Infant: PO Fumarate Low birth weight, 2 mg/kg/d up to 15 mg/d; ???, 1 mg/kg/d (max: 15 mg/d)
- Give on an empty stomach if possible because oral iron preparations are best absorbed then (i.e., between meals). Minimize
gastric distress if needed by giving with or immediately after meals with adequate liquid.
- Do not crush tablet or empty contents of capsule when administering.
- Do not give tablets or capsules within 1 h of bedtime.
- Consult physician about prescribing a liquid formulation or a less corrosive form, such as ferrous gluconate, if the patient
experiences difficulty in swallowing tablet or capsule.
- Dilute liquid preparations well and give through a straw or placed on the back of tongue with a dropper to prevent staining
of teeth and to mask taste. Instruct the patient to rinse mouth with clear water immediately after ingestion.
- Mix ferosol elixir with water; not compatible with milk or fruit juice. Fer-In-Sol (drops) may be given in water or in fruit
or vegetable juice, according to manufacturer.
- Do not use discolored tablets.
- Store in tightly closed containers and protect from moisture. Store at 15°30° C (59°86°
Adverse Effects (≥1%)GI: Nausea, heartburn,
diarrhea, epigastric pain, abdominal distress, black stools. Special Senses:
Yellow-brown discoloration of eyes and teeth (liquid forms). Large Chronic Doses in Infants
Rickets (due to interference with phosphorus absorption). Massive Overdosage
Lethargy, drowsiness, nausea, vomiting, abdominal pain, diarrhea, local corrosion of stomach and small intestines, pallor
or cyanosis, metabolic acidosis, shock, cardiovascular collapse
, convulsions, liver necrosis
, coma, renal failure, death
Diagnostic Test Interference
By coloring feces black, large iron doses may cause false-positive tests for occult blood with orthotoluidine (Hematest, Occultist, Labstix); guaiac reagent benzidine test is reportedly not affected.
decrease iron absorption; iron decreases absorption of tetracyclines
, ciprofloxacin, ofloxacin; chloramphenicol
may delay iron's effects; iron may decrease absorption of penicillamine. Food:
Food decreases absorption of iron; ascorbic acid (vitamin C)
may increase iron absorption.
510% absorbed in healthy individuals; 1030% absorbed in iron-deficiency; food decreases amount absorbed. Distribution:
Transported by transferrin to bone marrow, where it is incorporated into hemoglobin; crosses placenta. Elimination:
Most of iron released from hemoglobin is reused in body; small amounts are lost in desquamation of skin, GI mucosa, nails,
and hair; 1230 mg/mo lost through menstruation.
Assessment & Drug Effects
- Lab tests: Monitor Hgb and reticulocyte values during therapy. Investigate the absence of satisfactory response after 3 wk
of drug treatment.
- Continue iron therapy for 23 mo after the hemoglobin level has returned to normal (roughly twice the period required
to normalize hemoglobin concentration).
- Monitor bowel movements as constipation is a common adverse effect.
Patient & Family Education
- Note: Ascorbic acid increases absorption of iron. Consuming citrus fruit or tomato juice with iron preparation (except the elixir)
may increase its absorption.
- Be aware that milk, eggs, or caffeine beverages when taken with the iron preparation may inhibit absorption.
- Be aware that iron preparations cause dark green or black stools.
- Report constipation or diarrhea to physician; symptoms may be relieved by adjustments in dosage or diet or by change to another